 | • レポートコード：QAF27767 • 出版社/出版日：QYResearch / 2021年5月20日 • レポート形態：英文、PDF、136ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のリラグルチド市場について種類別（錠剤、液体）、用途別（病院、ドラッグストア）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・リラグルチド市場の概要 ・世界の主要地域別リラグルチド市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のリラグルチド市場規模2016-2021：種類別（錠剤、液体） ・世界のリラグルチド市場予測2012-2027：種類別（錠剤、液体） ・世界のリラグルチド市場規模2016-2021：用途別（病院、ドラッグストア） ・世界のリラグルチド市場予測2012-2027：用途別（病院、ドラッグストア） ・リラグルチドのアメリカ市場規模と予測2016-2021 ・リラグルチドのヨーロッパ市場規模と予測2016-2021 ・リラグルチドの中国市場規模と予測2016-2021 ・リラグルチドの日本市場規模と予測2016-2021 ・リラグルチドの東南アジア市場規模と予測2016-2021 ・リラグルチドのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （HEC Pharm、Bachem、Bharat Pharmaceuticals、Kingpep Biotechnology、Shenzhen JYMed Technology、Wuxi Asiapeptide、AmbioPharm） ・リラグルチドの製造コスト分析 ・販売チャネル、流通業者、顧客 ・リラグルチドの市場動向・機会・課題 ・調査の結論 |
Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition.
The total amount of Patents about Liraglutide are 1871, among those Patents, 44%is about application, 26%is about Combination therapy, and 12%is about Preparation method.
In these patents, accounting for Europe is the largest, followed by North America, and finally Asia.
The application of Liraglutide
Liraglutide for the treatment of type 2 diabetes mellitus
Liraglutide 1.2 mg daily in triple therapy regimens (in combination with metformin and a sulphonylurea, or metformin and a thiazolidinedione) is recommended as an option for the treatment of people with type 2 diabetes, only if used as described for exenatide in ‘Type 2 diabetes: the management of type 2 diabetes’
Liraglutide 1.2 mg daily in dual therapy regimens (in combination with metformin or a sulphonylurea) is recommended as an option for the treatment of people with type 2 diabetes, only if the person is intolerant of either metformin or a sulphonylurea, or treatment with metformin or a sulphonylurea is contraindicated, and the person is intolerant of thiazolidinediones and dipeptidyl peptidase-4 (DPP-4) inhibitors, or treatment with thiazolidinediones and DPP-4 inhibitors is contraindicated.
Liraglutide 1.8 mg daily is not recommended for the treatment of people with type 2 diabetes.
The Committee concluded that the evidence provided was not robust enough to allow it to recommend liraglutide as a cost-effective alternative to either thiazolidinediones or DPP-4 inhibitors as a triple therapy regimen, however it believes liraglutide is a cost-effective treatment option relative to exenatide.
Taking into account the lack of clinical trial evidence showing a significant benefit from increasing the liraglutide dose from 1.2 mg to 1.8 mg, the widely varying ICERs and the uncertainty in the economic analysis, the Committee was unable to recommend liraglutide 1.8 mg for the treatment of type 2 diabetes.
The Committee concluded that people with type 2 diabetes currently receiving liraglutide who do not meet the criteria specified in section 1.1 or 1.3, or who are receiving liraglutide 1.8 mg, should have the option to continue their current treatment until they and their clinicians consider it appropriate to stop.
Market Analysis and Insights: Global Liraglutide Market
The global Liraglutide market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.
Global Liraglutide Scope and Market Size
The global Liraglutide market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Liraglutide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Pills
Liquid
Segment by Application
Hospital
Drug Store
The Liraglutide market is analysed and market size information is provided by regions (countries). Segment by Application, the Liraglutide market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
HEC Pharm
Bachem
Bharat Pharmaceuticals
Kingpep Biotechnology
Shenzhen JYMed Technology
Wuxi Asiapeptide
AmbioPharm
1 Liraglutide Market Overview
1.1 Liraglutide Product Scope
1.2 Liraglutide Segment by Type
1.2.1 Global Liraglutide Sales by Type (2016 & 2021 & 2027)
1.2.2 Pills
1.2.3 Liquid
1.3 Liraglutide Segment by Application
1.3.1 Global Liraglutide Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Liraglutide Market Estimates and Forecasts (2016-2027)
1.4.1 Global Liraglutide Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Liraglutide Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Liraglutide Price Trends (2016-2027)
2 Liraglutide Estimates and Forecasts by Region
2.1 Global Liraglutide Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Liraglutide Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Liraglutide Sales Market Share by Region (2016-2021)
2.2.2 Global Liraglutide Revenue Market Share by Region (2016-2021)
2.3 Global Liraglutide Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Liraglutide Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Liraglutide Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Liraglutide Estimates and Projections (2016-2027)
2.4.2 Europe Liraglutide Estimates and Projections (2016-2027)
2.4.3 China Liraglutide Estimates and Projections (2016-2027)
2.4.4 Japan Liraglutide Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Liraglutide Estimates and Projections (2016-2027)
2.4.6 India Liraglutide Estimates and Projections (2016-2027)
3 Global Liraglutide Competition Landscape by Players
3.1 Global Top Liraglutide Players by Sales (2016-2021)
3.2 Global Top Liraglutide Players by Revenue (2016-2021)
3.3 Global Liraglutide Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Liraglutide as of 2020)
3.4 Global Liraglutide Average Price by Company (2016-2021)
3.5 Manufacturers Liraglutide Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Liraglutide Market Size by Type
4.1 Global Liraglutide Historic Market Review by Type (2016-2021)
4.1.1 Global Liraglutide Sales Market Share by Type (2016-2021)
4.1.2 Global Liraglutide Revenue Market Share by Type (2016-2021)
4.1.3 Global Liraglutide Price by Type (2016-2021)
4.2 Global Liraglutide Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Liraglutide Sales Forecast by Type (2022-2027)
4.2.2 Global Liraglutide Revenue Forecast by Type (2022-2027)
4.2.3 Global Liraglutide Price Forecast by Type (2022-2027)
5 Global Liraglutide Market Size by Application
5.1 Global Liraglutide Historic Market Review by Application (2016-2021)
5.1.1 Global Liraglutide Sales Market Share by Application (2016-2021)
5.1.2 Global Liraglutide Revenue Market Share by Application (2016-2021)
5.1.3 Global Liraglutide Price by Application (2016-2021)
5.2 Global Liraglutide Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Liraglutide Sales Forecast by Application (2022-2027)
5.2.2 Global Liraglutide Revenue Forecast by Application (2022-2027)
5.2.3 Global Liraglutide Price Forecast by Application (2022-2027)
6 North America Liraglutide Market Facts & Figures
6.1 North America Liraglutide Sales by Company
6.1.1 North America Liraglutide Sales by Company (2016-2021)
6.1.2 North America Liraglutide Revenue by Company (2016-2021)
6.2 North America Liraglutide Sales Breakdown by Type
6.2.1 North America Liraglutide Sales Breakdown by Type (2016-2021)
6.2.2 North America Liraglutide Sales Breakdown by Type (2022-2027)
6.3 North America Liraglutide Sales Breakdown by Application
6.3.1 North America Liraglutide Sales Breakdown by Application (2016-2021)
6.3.2 North America Liraglutide Sales Breakdown by Application (2022-2027)
7 Europe Liraglutide Market Facts & Figures
7.1 Europe Liraglutide Sales by Company
7.1.1 Europe Liraglutide Sales by Company (2016-2021)
7.1.2 Europe Liraglutide Revenue by Company (2016-2021)
7.2 Europe Liraglutide Sales Breakdown by Type
7.2.1 Europe Liraglutide Sales Breakdown by Type (2016-2021)
7.2.2 Europe Liraglutide Sales Breakdown by Type (2022-2027)
7.3 Europe Liraglutide Sales Breakdown by Application
7.3.1 Europe 136 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 136 Sales Breakdown by Application (2022-2027)
8 China Liraglutide Market Facts & Figures
8.1 China Liraglutide Sales by Company
8.1.1 China Liraglutide Sales by Company (2016-2021)
8.1.2 China Liraglutide Revenue by Company (2016-2021)
8.2 China Liraglutide Sales Breakdown by Type
8.2.1 China Liraglutide Sales Breakdown by Type (2016-2021)
8.2.2 China Liraglutide Sales Breakdown by Type (2022-2027)
8.3 China Liraglutide Sales Breakdown by Application
8.3.1 China 242 Sales Breakdown by Application (2016-2021)
8.3.2 China 242 Sales Breakdown by Application (2022-2027)
9 Japan Liraglutide Market Facts & Figures
9.1 Japan Liraglutide Sales by Company
9.1.1 Japan Liraglutide Sales by Company (2016-2021)
9.1.2 Japan Liraglutide Revenue by Company (2016-2021)
9.2 Japan Liraglutide Sales Breakdown by Type
9.2.1 Japan Liraglutide Sales Breakdown by Type (2016-2021)
9.2.2 Japan Liraglutide Sales Breakdown by Type (2022-2027)
9.3 Japan Liraglutide Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Liraglutide Market Facts & Figures
10.1 Southeast Asia Liraglutide Sales by Company
10.1.1 Southeast Asia Liraglutide Sales by Company (2016-2021)
10.1.2 Southeast Asia Liraglutide Revenue by Company (2016-2021)
10.2 Southeast Asia Liraglutide Sales Breakdown by Type
10.2.1 Southeast Asia Liraglutide Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Liraglutide Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Liraglutide Sales Breakdown by Application
10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)
11 India Liraglutide Market Facts & Figures
11.1 India Liraglutide Sales by Company
11.1.1 India Liraglutide Sales by Company (2016-2021)
11.1.2 India Liraglutide Revenue by Company (2016-2021)
11.2 India Liraglutide Sales Breakdown by Type
11.2.1 India Liraglutide Sales Breakdown by Type (2016-2021)
11.2.2 India Liraglutide Sales Breakdown by Type (2022-2027)
11.3 India Liraglutide Sales Breakdown by Application
11.3.1 India Liraglutide Sales Breakdown by Application (2016-2021)
11.3.2 India Liraglutide Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Liraglutide Business
12.1 HEC Pharm
12.1.1 HEC Pharm Corporation Information
12.1.2 HEC Pharm Business Overview
12.1.3 HEC Pharm Liraglutide Sales, Revenue and Gross Margin (2016-2021)
12.1.4 HEC Pharm Liraglutide Products Offered
12.1.5 HEC Pharm Recent Development
12.2 Bachem
12.2.1 Bachem Corporation Information
12.2.2 Bachem Business Overview
12.2.3 Bachem Liraglutide Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Bachem Liraglutide Products Offered
12.2.5 Bachem Recent Development
12.3 Bharat Pharmaceuticals
12.3.1 Bharat Pharmaceuticals Corporation Information
12.3.2 Bharat Pharmaceuticals Business Overview
12.3.3 Bharat Pharmaceuticals Liraglutide Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Bharat Pharmaceuticals Liraglutide Products Offered
12.3.5 Bharat Pharmaceuticals Recent Development
12.4 Kingpep Biotechnology
12.4.1 Kingpep Biotechnology Corporation Information
12.4.2 Kingpep Biotechnology Business Overview
12.4.3 Kingpep Biotechnology Liraglutide Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Kingpep Biotechnology Liraglutide Products Offered
12.4.5 Kingpep Biotechnology Recent Development
12.5 Shenzhen JYMed Technology
12.5.1 Shenzhen JYMed Technology Corporation Information
12.5.2 Shenzhen JYMed Technology Business Overview
12.5.3 Shenzhen JYMed Technology Liraglutide Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Shenzhen JYMed Technology Liraglutide Products Offered
12.5.5 Shenzhen JYMed Technology Recent Development
12.6 Wuxi Asiapeptide
12.6.1 Wuxi Asiapeptide Corporation Information
12.6.2 Wuxi Asiapeptide Business Overview
12.6.3 Wuxi Asiapeptide Liraglutide Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Wuxi Asiapeptide Liraglutide Products Offered
12.6.5 Wuxi Asiapeptide Recent Development
12.7 AmbioPharm
12.7.1 AmbioPharm Corporation Information
12.7.2 AmbioPharm Business Overview
12.7.3 AmbioPharm Liraglutide Sales, Revenue and Gross Margin (2016-2021)
12.7.4 AmbioPharm Liraglutide Products Offered
12.7.5 AmbioPharm Recent Development
…
13 Liraglutide Manufacturing Cost Analysis
13.1 Liraglutide Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Liraglutide
13.4 Liraglutide Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Liraglutide Distributors List
14.3 Liraglutide Customers
15 Market Dynamics
15.1 Liraglutide Market Trends
15.2 Liraglutide Drivers
15.3 Liraglutide Market Challenges
15.4 Liraglutide Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Liraglutide Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Liraglutide Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Liraglutide Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Liraglutide Sales (K MT) by Region (2016-2021)
Table 5. Global Liraglutide Sales Market Share by Region (2016-2021)
Table 6. Global Liraglutide Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Liraglutide Revenue Share by Region (2016-2021)
Table 8. Global Liraglutide Sales (K MT) Forecast by Region (2022-2027)
Table 9. Global Liraglutide Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Liraglutide Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Liraglutide Revenue Share Forecast by Region (2022-2027)
Table 12. Global Liraglutide Sales (K MT) of Key Companies (2016-2021)
Table 13. Global Liraglutide Sales Share by Company (2016-2021)
Table 14. Global Liraglutide Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Liraglutide Revenue Share by Company (2016-2021)
Table 16. Global Liraglutide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liraglutide as of 2020)
Table 17. Global Liraglutide Average Price (USD/MT) of Key Company (2016-2021)
Table 18. Manufacturers Liraglutide Manufacturing Sites and Area Served
Table 19. Manufacturers Liraglutide Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Liraglutide Sales (K MT) by Type (2016-2021)
Table 22. Global Liraglutide Sales Share by Type (2016-2021)
Table 23. Global Liraglutide Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Liraglutide Price (USD/MT) by Type (2016-2021)
Table 25. Global Liraglutide Sales Share by Type (2022-2027)
Table 26. Global Liraglutide Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Liraglutide Revenue Share by Type (2022-2027)
Table 28. Global Liraglutide Price (USD/MT) by Type (2022-2027)
Table 29. Global Liraglutide Sales (K MT) by Application (2016-2021)
Table 30. Global Liraglutide Sales Share by Application (2016-2021)
Table 31. Global Liraglutide Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Liraglutide Price (USD/MT) by Application (2016-2021)
Table 33. Global Liraglutide Sales (K MT) by Application (2022-2027)
Table 34. Global Liraglutide Sales Share by Application (2022-2027)
Table 35. Global Liraglutide Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Liraglutide Revenue Share by Application (2022-2027)
Table 37. Global Liraglutide Price (USD/MT) by Application (2022-2027)
Table 38. North America Liraglutide Sales (K MT) by Company (2016-2021)
Table 39. North America Liraglutide Sales Market Share by Company (2016-2021)
Table 40. North America Liraglutide Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Liraglutide Revenue Market Share by Company (2016-2021)
Table 42. North America Liraglutide Sales by Type (2016-2021) & (K MT)
Table 43. North America Liraglutide Sales Market Share by Type (2016-2021)
Table 44. North America Liraglutide Sales by Type (2022-2027) & (K MT)
Table 45. North America Liraglutide Sales Market Share by Type (2022-2027)
Table 46. North America Liraglutide Sales by Application (2016-2021) & (K MT)
Table 47. North America Liraglutide Sales Market Share by Application (2016-2021)
Table 48. North America Liraglutide Sales by Application (2022-2027) & (K MT)
Table 49. North America Liraglutide Sales Market Share by Application (2022-2027)
Table 50. Europe Liraglutide Sales (K MT) by Company (2016-2021)
Table 51. Europe Liraglutide Sales Market Share by Company (2016-2021)
Table 52. Europe Liraglutide Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Liraglutide Revenue Market Share by Company (2016-2021)
Table 54. Europe Liraglutide Sales by Type (2016-2021) & (K MT)
Table 55. Europe Liraglutide Sales Market Share by Type (2016-2021)
Table 56. Europe Liraglutide Sales by Type (2022-2027) & (K MT)
Table 57. Europe Liraglutide Sales Market Share by Type (2022-2027)
Table 58. Europe Liraglutide Sales by Application (2016-2021) & (K MT)
Table 59. Europe Liraglutide Sales Market Share by Application (2016-2021)
Table 60. Europe Liraglutide Sales by Application (2022-2027) & (K MT)
Table 61. Europe Liraglutide Sales Market Share by Application (2022-2027)
Table 62. China Liraglutide Sales (K MT) by Company (2016-2021)
Table 63. China Liraglutide Sales Market Share by Company (2016-2021)
Table 64. China Liraglutide Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Liraglutide Revenue Market Share by Company (2016-2021)
Table 66. China Liraglutide Sales by Type (2016-2021) & (K MT)
Table 67. China Liraglutide Sales Market Share by Type (2016-2021)
Table 68. China Liraglutide Sales by Type (2022-2027) & (K MT)
Table 69. China Liraglutide Sales Market Share by Type (2022-2027)
Table 70. China Liraglutide Sales by Application (2016-2021) & (K MT)
Table 71. China Liraglutide Sales Market Share by Application (2016-2021)
Table 72. China Liraglutide Sales by Application (2022-2027) & (K MT)
Table 73. China Liraglutide Sales Market Share by Application (2022-2027)
Table 74. Japan Liraglutide Sales (K MT) by Company (2016-2021)
Table 75. Japan Liraglutide Sales Market Share by Company (2016-2021)
Table 76. Japan Liraglutide Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Liraglutide Revenue Market Share by Company (2016-2021)
Table 78. Japan Liraglutide Sales by Type (2016-2021) & (K MT)
Table 79. Japan Liraglutide Sales Market Share by Type (2016-2021)
Table 80. Japan Liraglutide Sales by Type (2022-2027) & (K MT)
Table 81. Japan Liraglutide Sales Market Share by Type (2022-2027)
Table 82. Japan Liraglutide Sales by Application (2016-2021) & (K MT)
Table 83. Japan Liraglutide Sales Market Share by Application (2016-2021)
Table 84. Japan Liraglutide Sales by Application (2022-2027) & (K MT)
Table 85. Japan Liraglutide Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Liraglutide Sales (K MT) by Company (2016-2021)
Table 87. Southeast Asia Liraglutide Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Liraglutide Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Liraglutide Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Liraglutide Sales by Type (2016-2021) & (K MT)
Table 91. Southeast Asia Liraglutide Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Liraglutide Sales by Type (2022-2027) & (K MT)
Table 93. Southeast Asia Liraglutide Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Liraglutide Sales by Application (2016-2021) & (K MT)
Table 95. Southeast Asia Liraglutide Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Liraglutide Sales by Application (2022-2027) & (K MT)
Table 97. Southeast Asia Liraglutide Sales Market Share by Application (2022-2027)
Table 98. India Liraglutide Sales (K MT) by Company (2016-2021)
Table 99. India Liraglutide Sales Market Share by Company (2016-2021)
Table 100. India Liraglutide Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Liraglutide Revenue Market Share by Company (2016-2021)
Table 102. India Liraglutide Sales by Type (2016-2021) & (K MT)
Table 103. India Liraglutide Sales Market Share by Type (2016-2021)
Table 104. India Liraglutide Sales by Type (2022-2027) & (K MT)
Table 105. India Liraglutide Sales Market Share by Type (2022-2027)
Table 106. India Liraglutide Sales by Application (2016-2021) & (K MT)
Table 107. India Liraglutide Sales Market Share by Application (2016-2021)
Table 108. India Liraglutide Sales by Application (2022-2027) & (K MT)
Table 109. India Liraglutide Sales Market Share by Application (2022-2027)
Table 110. HEC Pharm Corporation Information
Table 111. HEC Pharm Description and Business Overview
Table 112. HEC Pharm Liraglutide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. HEC Pharm Liraglutide Product
Table 114. HEC Pharm Recent Development
Table 115. Bachem Corporation Information
Table 116. Bachem Description and Business Overview
Table 117. Bachem Liraglutide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. Bachem Liraglutide Product
Table 119. Bachem Recent Development
Table 120. Bharat Pharmaceuticals Corporation Information
Table 121. Bharat Pharmaceuticals Description and Business Overview
Table 122. Bharat Pharmaceuticals Liraglutide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. Bharat Pharmaceuticals Liraglutide Product
Table 124. Bharat Pharmaceuticals Recent Development
Table 125. Kingpep Biotechnology Corporation Information
Table 126. Kingpep Biotechnology Description and Business Overview
Table 127. Kingpep Biotechnology Liraglutide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. Kingpep Biotechnology Liraglutide Product
Table 129. Kingpep Biotechnology Recent Development
Table 130. Shenzhen JYMed Technology Corporation Information
Table 131. Shenzhen JYMed Technology Description and Business Overview
Table 132. Shenzhen JYMed Technology Liraglutide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 133. Shenzhen JYMed Technology Liraglutide Product
Table 134. Shenzhen JYMed Technology Recent Development
Table 135. Wuxi Asiapeptide Corporation Information
Table 136. Wuxi Asiapeptide Description and Business Overview
Table 137. Wuxi Asiapeptide Liraglutide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 138. Wuxi Asiapeptide Liraglutide Product
Table 139. Wuxi Asiapeptide Recent Development
Table 140. AmbioPharm Corporation Information
Table 141. AmbioPharm Description and Business Overview
Table 142. AmbioPharm Liraglutide Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 143. AmbioPharm Liraglutide Product
Table 144. AmbioPharm Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Liraglutide Distributors List
Table 148. Liraglutide Customers List
Table 149. Liraglutide Market Trends
Table 150. Liraglutide Market Drivers
Table 151. Liraglutide Market Challenges
Table 152. Liraglutide Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Liraglutide Product Picture
Figure 2. Global Liraglutide Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Liraglutide Sales Market Share by Application in 2021 & 2027
Figure 6. Hospital Examples
Figure 7. Drug Store Examples
Figure 8. Global Liraglutide Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Liraglutide Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Liraglutide Sales (K MT) Growth Rate (2016-2027)
Figure 11. Global Liraglutide Price Trends Growth Rate (2016-2027) (USD/MT)
Figure 12. Global Liraglutide Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Liraglutide Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Liraglutide Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Liraglutide Sales (K MT) Growth Rate (2016-2027)
Figure 16. Europe Liraglutide Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Liraglutide Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Liraglutide Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Liraglutide Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Liraglutide Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Liraglutide Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Liraglutide Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Liraglutide Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Liraglutide Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Liraglutide Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Liraglutide Players Market Share by Revenue in Liraglutide: 2016 & 2020
Figure 27. Liraglutide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Liraglutide Revenue Share by Type (2016-2021)
Figure 29. Global Liraglutide Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Liraglutide Revenue Share by Application (2016-2021)
Figure 31. Global Liraglutide Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Liraglutide Sales Market Share by Type in 2020
Figure 33. North America Liraglutide Sales Market Share by Application in 2020
Figure 34. Europe Liraglutide Sales Market Share by Type in 2020
Figure 35. Europe Liraglutide Sales Market Share by Application in 2020
Figure 36. China Liraglutide Sales Market Share by Type in 2020
Figure 37. China Liraglutide Sales Market Share by Application in 2020
Figure 38. Japan Liraglutide Sales Market Share by Type in 2020
Figure 39. Japan Liraglutide Sales Market Share by Application in 2020
Figure 40. Southeast Asia Liraglutide Sales Market Share by Type in 2020
Figure 41. Southeast Asia Liraglutide Sales Market Share by Application in 2020
Figure 42. India Liraglutide Sales Market Share by Type in 2020
Figure 43. India Liraglutide Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Liraglutide
Figure 46. Manufacturing Process Analysis of Liraglutide
Figure 47. Liraglutide Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed